Acer Therapeutics Inc.
NASDAQ:ACER
Overview | Financials
Company Name | Acer Therapeutics Inc. |
Symbol | ACER |
Currency | USD |
Price | 0.9 |
Market Cap | 22,017,330 |
Dividend Yield | 0% |
52-week-range | 0.9 - 0.9 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Christopher Schelling |
Website | https://www.acertx.com |
An error occurred while fetching data.
About Acer Therapeutics Inc.
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD